Literature DB >> 8188931

Acantholytic dermatosis localized to genitalia and crural areas of male patients: a report of three cases.

T Y Wong1, M C Mihm.   

Abstract

A series of 3 cases of acantholytic dermatosis localized to the male genitalia and perineal area with distinct clinical and histological features is presented. These patients did not have a family history of similar disorders and had no evidence of rash elsewhere. Clinically, the eruption was characterized by multiple discrete papules or macerated patches involving the genitalia and the perineum. Histologically, the acantholytic dermatosis had features that resembled both Hailey-Hailey disease and Darier's disease. Similar clinical and histological findings have been reported in females. To the best of our knowledge, this is the first report of these lesions described confined to the genital and perineal areas in male patients. We agree with other authors that this condition may represent a distinct acantholytic eruption in the perineal area that should be distinguished from other generalized blistering acantholytic dyskeratotic disorders that may also involve the genitalia.

Entities:  

Mesh:

Year:  1994        PMID: 8188931     DOI: 10.1111/j.1600-0560.1994.tb00687.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  3 in total

1.  Somatic ATP2A2 mutation in a case of papular acantholytic dyskeratosis: mosaic Darier disease.

Authors:  Eleanor A Knopp; Corey Saraceni; Jeremy Moss; Jennifer M McNiff; Keith A Choate
Journal:  J Cutan Pathol       Date:  2015-08-12       Impact factor: 1.587

2.  Papular acantholytic dyskeratosis of the genitocrural area: A rare unilateral asymptomatic intertrigo.

Authors:  Margaret L Dowd; Leah H Ansell; Sameera Husain; Marc E Grossman
Journal:  JAAD Case Rep       Date:  2016-03-05

3.  Papular acantholytic dyskeratosis localized to the perineal and perianal area in a young male.

Authors:  Shyam B Verma
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.